Facebook $449 Million by 2032: Why the Coagulation Factor IX (Human) Market Remains the Irreplaceable Backbone of Hemophilia B Emergency Care
Logo

$449 Million by 2032: Why the Coagulation Factor IX (Human) Market Remains the Irreplaceable Backbone of Hemophilia B Emergency Care

クレジット
Avatar
インタビューワー
$449 Million by 2032: Why the Coagulation Factor IX (Human) Market Remains the Irreplaceable Backbone of Hemophilia B Emergency Care-1
シェア
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/
$449 Million by 2032: Why the Coagulation Factor IX (Human) Market Remains the Irreplaceable Backbone of Hemophilia B Emergency Care-1
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/